Capital Fund Management (CFM)’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.34M | Sell |
15,500
-113,500
| -88% | -$10.9M | 0.01% | 1552 |
|
|
2025
Q4 | $12.4M | Buy |
129,000
+92,300
| +251% | +$8.97M | 0.03% | 712 |
|
|
2025
Q3 | $3.5M | Sell |
36,700
-31,900
| -47% | -$2.93M | 0.01% | 1463 |
|
|
2025
Q2 | $5.98M | Buy |
68,600
+48,700
| +245% | +$4.13M | 0.02% | 1029 |
|
|
2025
Q1 | $1.79M | Sell |
19,900
-62,400
| -76% | -$5.58M | 0.01% | 1461 |
|
|
2024
Q4 | $6.57M | Sell |
82,300
-143,400
| -64% | -$12.4M | 0.02% | 957 |
|
|
2024
Q3 | $20.3M | Buy |
225,700
+34,500
| +18% | +$2.9M | 0.06% | 449 |
|
|
2024
Q2 | $15M | Sell |
191,200
-403,900
| -68% | -$33.1M | 0.04% | 515 |
|
|
2024
Q1 | $51.9M | Buy |
595,100
+146,300
| +33% | +$12.5M | 0.15% | 186 |
|
|
2023
Q4 | $37M | Buy |
448,800
+38,300
| +9% | +$2.92M | 0.1% | 282 |
|
|
2023
Q3 | $32.2M | Buy |
410,500
+303,100
| +282% | +$25.4M | 0.11% | 236 |
|
|
2023
Q2 | $9.46M | Sell |
107,400
-270,100
| -72% | -$23.3M | 0.04% | 583 |
|
|
2023
Q1 | $30.4M | Buy |
377,500
+145,900
| +63% | +$11.9M | 0.15% | 190 |
|
|
2022
Q4 | $18M | Buy |
231,600
+67,400
| +41% | +$5.46M | 0.12% | 230 |
|
|
2022
Q3 | $13.3M | Buy |
164,200
+133,400
| +433% | +$12M | 0.1% | 251 |
|
|
2022
Q2 | $2.76M | Sell |
30,800
-42,300
| -58% | -$4.29M | 0.03% | 716 |
|
|
2022
Q1 | $8.11M | Buy |
+73,100
| New | +$7.72M | 0.07% | 400 |
|
|
2020
Q3 | – | Sell |
-16,200
| Closed | -$1.49M | – | 1321 |
|
|
2020
Q2 | $1.49M | Sell |
16,200
-26,100
| -62% | -$2.5M | 0.02% | 592 |
|
|
2020
Q1 | $3.81M | Buy |
42,300
+33,900
| +404% | +$3.61M | 0.06% | 360 |
|
|
2019
Q4 | $953K | Buy |
8,400
+300
| +4% | +$32.9K | 0.01% | 1103 |
|
|
2019
Q3 | $880K | Buy |
+8,100
| New | +$845K | 0.01% | 1058 |
|
|
2019
Q1 | – | Sell |
-82,400
| Closed | -$7.5M | – | 1932 |
|
|
2018
Q4 | $7.5M | Sell |
82,400
-137,200
| -62% | -$12.8M | 0.07% | 391 |
|
|
2018
Q3 | $21.6M | Buy |
219,600
+78,900
| +56% | +$7.29M | 0.12% | 249 |
|
|
2018
Q2 | $12M | Buy |
+140,700
| New | +$11.8M | 0.06% | 423 |
|
|
2017
Q4 | – | Sell |
-12,800
| Closed | -$995K | – | 1908 |
|
|
2017
Q3 | $995K | Sell |
12,800
-15,700
| -55% | -$1.3M | 0.01% | 974 |
|
|
2017
Q2 | $2.53M | Buy |
+28,500
| New | +$2.4M | 0.02% | 653 |
|
|
2017
Q1 | – | Sell |
-15,200
| Closed | -$1.08M | – | 1687 |
|
|
2016
Q4 | $1.08M | Buy |
+15,200
| New | +$1.19M | 0.01% | 994 |
|
|
2016
Q3 | – | Sell |
-31,700
| Closed | -$2.75M | – | 1705 |
|
|
2016
Q2 | $2.75M | Buy |
+31,700
| New | +$2.56M | 0.03% | 634 |
|
|
2015
Q4 | – | Sell |
-28,000
| Closed | -$1.87M | – | 1649 |
|
|
2015
Q3 | $1.87M | Buy |
28,000
+13,400
| +92% | +$987K | 0.02% | 642 |
|
|
2015
Q2 | $1.08M | Sell |
14,600
-112,600
| -89% | -$8.6M | 0.01% | 807 |
|
|
2015
Q1 | $9.92M | Buy |
127,200
+30,500
| +32% | +$2.31M | 0.14% | 198 |
|
|
2014
Q4 | $6.98M | Sell |
96,700
-12,900
| -12% | -$896K | 0.08% | 331 |
|
|
2014
Q3 | $6.79M | Buy |
109,600
+40,900
| +60% | +$2.6M | 0.08% | 331 |
|
|
2014
Q2 | $4.38M | Buy |
68,700
+45,700
| +199% | +$2.78M | 0.05% | 458 |
|
|
2014
Q1 | $1.42M | Buy |
23,000
+16,600
| +259% | +$967K | 0.02% | 817 |
|
|
2013
Q4 | $367K | Sell |
6,400
-700
| -10% | -$39.7K | ﹤0.01% | 1376 |
|
|
2013
Q3 | $378K | Buy |
+7,100
| New | +$382K | 0.01% | 1271 |
|
Other funds holding MDT
VCM
VPM
Capital Fund Management (CFM)'s MDT Position: Q1 2026 in Review
Capital Fund Management (CFM) opened a new position in Medtronic (MDT) in Q1 2026: 61,660 shares worth $5.34M. The stake represents 0.02% of the portfolio and ranks #864 among its holdings. This is a return to the name: Capital Fund Management (CFM) previously reported a position in MDT as recently as Q2 2025.
Capital Fund Management (CFM) first reported a position in MDT in Q4 2013 and has held it in 22 quarters since. The position peaked at $54.7M in Q4 2016. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Capital Fund Management (CFM) held 61,660 shares of Medtronic worth $5.34M as of Q1 2026.
- Medtronic was a new Capital Fund Management (CFM) position in Q1 2026.
- Medtronic made up 0.02% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #864 holding.
- Capital Fund Management (CFM) first reported a position in Medtronic in Q4 2013 and has held it in 22 quarters since.
- Capital Fund Management (CFM)'s Medtronic position peaked at $54.7M in Q4 2016.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.